Inhibition of experimental auto-immune uveitis by the A3 adenosine receptor agonist CF101.
about
The role of adenosinergic pathway in human autoimmune diseasesBoth MC5r and A2Ar are required for protective regulatory immunity in the spleen of post-experimental autoimmune uveitis in miceRoles of the adenosine receptor and CD73 in the regulatory effect of γδ T cells.A₃ adenosine receptor allosteric modulator induces an anti-inflammatory effect: in vivo studies and molecular mechanism of action.Spinal neuroimmune activation is independent of T-cell infiltration and attenuated by A3 adenosine receptor agonists in a model of oxaliplatin-induced peripheral neuropathy.Pharmacological and therapeutic effects of A3 adenosine receptor agonistsTruncated Nucleosides as A(3) Adenosine Receptor Ligands: Combined 2-Arylethynyl and Bicyclohexane SubstitutionsRational design of sulfonated A3 adenosine receptor-selective nucleosides as pharmacological tools to study chronic neuropathic pain.Activation of liver X receptor alleviates ocular inflammation in experimental autoimmune uveitis.Allosteric interactions at adenosine A(1) and A(3) receptors: new insights into the role of small molecules and receptor dimerization.Purinergic receptors in ocular inflammation.A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy.Ocular Purine Receptors as Drug Targets in the Eye.Kinetic analysis of antagonist-occupied adenosine-A3 receptors within membrane microdomains of individual cells provides evidence of receptor dimerization and allosterism.Inhibition of IL-17 and IL-23 in Human Keratinocytes by the A3 Adenosine Receptor Agonist Piclidenoson.The Role of Extracellular Adenosine Generation in the Development of Autoimmune Diseases.
P2860
Q28069199-AB7A7373-C046-407E-8075-4FCB9F8EB3BDQ28298659-AAAFBE8C-F086-4E91-BEAF-78567059177DQ34277485-402D4A2A-94B2-480B-818C-FE48927D1713Q34412639-70ED61D2-7D9D-43CE-8121-0F04AEFC7435Q34765028-A8DC405C-BBD6-4B30-B810-A5DB4C951618Q35788500-E35ED5DD-8C56-4488-8252-383A963D2BC9Q36377951-E764E70E-BC53-46DF-977A-15EE84E51AACQ37381136-D2F86FD2-D795-49F4-BCC6-BC826EF9E73DQ37731895-84F2EA0B-7685-4327-B192-F201B797C8CBQ38136285-54F21105-16E5-497E-ABDF-744201DDE573Q38240836-C0535244-A81E-44E8-85B9-ACF3BD182613Q39418010-08C6C454-2038-4255-A975-8C82E50A5D80Q41651208-5DA0892E-1135-4137-8672-4257C27F4766Q42950461-CB954931-1B40-4177-88FB-802ECE1581B7Q54974227-56EDC244-4556-4291-9956-A779618C87A1Q55261560-B8F19A14-6677-47C9-8AF9-D9991ADEDED1
P2860
Inhibition of experimental auto-immune uveitis by the A3 adenosine receptor agonist CF101.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Inhibition of experimental aut ...... nosine receptor agonist CF101.
@ast
Inhibition of experimental aut ...... nosine receptor agonist CF101.
@en
type
label
Inhibition of experimental aut ...... nosine receptor agonist CF101.
@ast
Inhibition of experimental aut ...... nosine receptor agonist CF101.
@en
prefLabel
Inhibition of experimental aut ...... nosine receptor agonist CF101.
@ast
Inhibition of experimental aut ...... nosine receptor agonist CF101.
@en
P2093
P2860
P356
P1476
Inhibition of experimental aut ...... nosine receptor agonist CF101.
@en
P2093
Avivit Ochaion
Dror Luger
Galina Zozulya
Jose Maria Garcia Ruiz de Morales
Phyllis B Silver
Renana Patokaa
Sara Bar-Yehuda
Shira Cohen
P2860
P304
P356
10.3892/IJMM.2011.753
P577
2011-07-19T00:00:00Z